Company is winding down global enrollment for the RASolute 302 clinical trial studying daraxonrasib in patients with previously treated PDAC and ...

Ramp reports LLCs should seek business credit cards to separate expenses, manage cash flow, and build credit, helping streamline operations.

YETI Holdings, Inc. ("YETI") (NYSE: YETI) today announced its financial results for the third quarter ended September 27, 2025. YETI reports its financial performance in accordance with accounting ...

As of September 30, 2025, Corvus had cash, cash equivalents and marketable securities of $65.7 million as compared to $52.0 million as of December 31, 2024. Consistent with last quarter, Corvus ...

Q3 2025 Earnings Call November 6, 2025 8:00 AM ESTCompany ParticipantsSven Kopsel - Vice President of Investor ...

Net Income -- $71 million in net income for Q3 2025, equating to $1.42 per diluted share reported for Q3 2025. Adjusted Net ...

Teva reports revenues of $4.5 billion in the third quarter of 2025, an increase of 3% year-over-year (YoY) in U.S. dollars or 1% in local currency (LC). Excluding Japan BV in Q3 2024, revenues ...

It argues that Nasdaq-100 Index ETFs are not optimal for large-cap growth investors when considering diversification, growth, ...

Q3 2025 Earnings Call Transcript November 6, 2025 Solventum Corporation beats earnings expectations. Reported EPS is $1.5, expectations were $1.43. Operator: Good afternoon. My name is Regina, and I ...

Pason Systems Inc. (“Pason” or the “Company”) (TSX: PSI) (OTC: PSYTF) announced today its 2025 third quarter results and the declaration of a quarterly dividend.

TG Therapeutics, Inc. (NASDAQ: TGTX) Q3 2025 Earnings Call Transcript November 3, 2025 TG Therapeutics, Inc. beats earnings ...

Operator: Good morning, ladies and gentlemen, and welcome to the Cooper-Standard Third Quarter 2025 Earnings Conference Call.